Nat Metab
Efficacy and safety of albiglutide, a once-weekly glucagon-like peptide-1 receptor agonist, in patients with type 2 diabetes: a systematic review and meta-analysis
GLP-1 medications work, in part, by slowing down how quickly food passes through the stomach, leading people to feel fuller longer
While Semaglutide offers significant benefits for managing diabetes and weight loss, it may also lead to gastrointestinal issues such as nausea, vomiting, and diarrhea
The treatment begins at a low dose of 0.25 mg per week, which increases progressively to 2.4 mg over time
This leads to reduced calorie consumption and gradual, sustained weight loss